Web Results

en.wikipedia.org/wiki/Rosiglitazone

Rosiglitazone (trade name Avandia) is an antidiabetic drug in the thiazolidinedione class. .... There was no difference in all cause and vascular death in a meta-analysis of 4 ... It doubled the risk of fractures among women with type 2 diabetes, without a ... Both rosiglitazone and pioglitazone have been suspected of causing ...

www.medscape.com/viewarticle/739080

Mar 24, 2011 ... Following reports of cardiovascular risks with the antidiabetic drug rosiglitazone ( Avandia), clinicians wonder if pioglitazone (Actos) carries ...

www.aafp.org/afp/2009/1115/p1165.html

Nov 15, 2009 ... Head-to-head comparisons of these two drugs have been rare, and have ... rates between patients starting rosiglitazone and pioglitazone.

www.jwatch.org/jw201104070000001/2011/04/07/rosiglitazone-vs-pioglitazone-what-are-odds

Apr 7, 2011 ... The two thiazolidinediones available to treat type 2 diabetes in the U.S. are pioglitazone (Actos) and rosiglitazone (Avandia). Rosiglitazone ...

www.hindawi.com/journals/ppar/2008/520465

Jun 8, 2008 ... Comparison of Lipid Effects of Pioglitazone and Rosiglitazone in ... Again, there was a difference in HDL particle subclasses between the ...

www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM224739.pdf

Jul 13, 2010 ... Pioglitazone Meta-Analysis. 3. Pioglitazone and Rosiglitazone Meta-Analyses ... analysis in order to compare indirectly the cardiovascular safety of the ... Large trials were not comparable between the drugs. • 29 trials satisfied ...

www.ncbi.nlm.nih.gov/pubmed/18220664

Two head-to-head RCTs of type 2 diabetes demonstrated significant improvements in A1c in both groups at follow-up with no significant difference between ...

www.ncbi.nlm.nih.gov/pubmed/18826750

Oct 2, 2008 ... Pioglitazone versus rosiglitazone treatment in patients with type 2 diabetes and ... was used to simulate changes in glycosylated hemoglobin (HbA(1c)), ... effects of pioglitazone (n = 400) and rosiglitazone (n = 402) among ...

www.ncbi.nlm.nih.gov/pubmed/15983299

A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients ... by 13.1 +/- 7.8 mg/dl with rosiglitazone (P < 0.001 between treatments) .

www.uptodate.com/contents/thiazolidinediones-in-the-treatment-of-diabetes-mellitus

Apr 27, 2017 ... Two thiazolidinediones (rosiglitazone and pioglitazone) are currently ... tissue-- understanding obesity-related changes in regulation of lipid and ..... Pioglitazone and risk of bladder cancer among diabetic patients in France: a ...